These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7960355

  • 1. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
    Nada M, Hanafi S, al-Omari H, Mokhtar M, el-Shamy S, Mühlbacher J.
    Int J Dermatol; 1994 Aug; 33(8):570-2. PubMed ID: 7960355
    [No Abstract] [Full Text] [Related]

  • 2. Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis.
    el Darouti MA, Kalinka P.
    Int J Dermatol; 1990 Sep; 29(7):521-2. PubMed ID: 2228386
    [No Abstract] [Full Text] [Related]

  • 3. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ, Kircik LH.
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [Abstract] [Full Text] [Related]

  • 4. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin.
    Evans EG, James IG, Seaman RA, Richardson MD.
    Br J Dermatol; 1993 Oct; 129(4):437-42. PubMed ID: 8217759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses.
    Havlickova B, Friedrich M.
    Mycoses; 2008 Sep; 51 Suppl 4():16-26. PubMed ID: 18783560
    [Abstract] [Full Text] [Related]

  • 9. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
    Gold M, Dhawan S, Verma A, Kuligowski M, Dobrowski D.
    J Drugs Dermatol; 2016 Jun 01; 15(6):743-8. PubMed ID: 27272083
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB, Verma A, Olayinka B, Hardas B.
    J Drugs Dermatol; 2013 Aug 01; 12(8):911-8. PubMed ID: 23986165
    [Abstract] [Full Text] [Related]

  • 13. Naftifine: a topical allylamine antifungal agent.
    Mühlbacher JM.
    Clin Dermatol; 1991 Aug 01; 9(4):479-85. PubMed ID: 1822408
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Daktacort in skin lesions.
    Fischman O, Levites J, Grinblat M.
    Mykosen; 1977 Dec 01; 20(12):471-5. PubMed ID: 600303
    [No Abstract] [Full Text] [Related]

  • 16. New and prospective developments in antifungal drugs.
    Cauwenbergh G.
    Acta Derm Venereol Suppl (Stockh); 1986 Dec 01; 121():147-53. PubMed ID: 3012922
    [Abstract] [Full Text] [Related]

  • 17. Allylamines: topical and oral treatment of dermatomycoses with a new class of antifungal agents.
    Ganzinger U, Stutz A, Petranyi G, Stephen A.
    Acta Derm Venereol Suppl (Stockh); 1986 Dec 01; 121():155-60. PubMed ID: 3459341
    [Abstract] [Full Text] [Related]

  • 18. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Jul 01; 14(7):686-91. PubMed ID: 26151784
    [Abstract] [Full Text] [Related]

  • 19. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis.
    Jordon RE, Rapini RP, Rex IH, Katz HI, Hickman JG, Bard JW, Medansky RS, Lew-Kaya DA, Sefton J, DeGryse RE.
    Int J Dermatol; 1990 Jul 01; 29(6):441-2. PubMed ID: 2397973
    [Abstract] [Full Text] [Related]

  • 20. Miconazole in the treatment of dermatomycosis.
    Thulin H, Osterbye P.
    Mykosen; 1975 May 01; 18(5):249-53. PubMed ID: 1160934
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.